IGC Pharma Statistics
NYSE: IGCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.168-0.016 (-8.70%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
IGC Pharma by the numbers
IGC Pharma has a market capitalization of $19.6 million based on 116.69M shares outstanding. With trailing EPS of $-0.07, IGC Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.2% below its 50-day average and 38.5% below its 200-day average.
Average daily trading volume is 615.25K shares, or about $103,361 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IGC valuation vs. peer median
| Metric | IGC | Peer median | Difference |
|---|---|---|---|
| Market cap | $19.60M | $19.33M | +1% |
| Avg. volume | 615.25K | 457.29K | +35% |
Peer median across 8 companies: TXMD, ACET, RNAZ, AARD, CPHI, COCP, MRKR, KTTA.
Valuation
- Market cap
- $19.60M
- Price / sales (latest FY)
- 15.42
- EPS (TTM)
- $-0.07
- Shares outstanding
- 116.69M
Price and trading
- Previous close
- 0.184
- Open
- 0.1832
- Day range
- 0.168 – 0.1863
- 52-week range
- 0.08 – 0.36
- 52-week change
- -47.50%
- 50-day moving average
- 0.2406
- 200-day moving average
- 0.2732
- Beta
- —
- Volume
- 500.33K
- Average volume
- 615.25K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 19.60M
- Forward Pe
- -2.10
- Eps
- -0.07
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 0.36
- Week52 Low
- 0.08
- Avg Volume
- 615.25K
- Shares Outstanding
- 116.69M
- Ma50
- 0.24
- Ma200
- 0.27
- Pct From52w High
- -53.33%
- Pct From52w Low
- 110.00%